PAVmed to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 07 2016 - 4:05PM
Business Wire
PAVmed Inc. (Nasdaq: PAVM), a highly differentiated,
multi-product medical device company, today announced that Lishan
Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will
present at the Rodman & Renshaw 18th Annual Global Investment
Conference on Tuesday, September 13, 2016, at 5:05 pm ET taking
place at the Lotte New York Palace Hotel in New York City. Dr.
Aklog will provide a corporate overview, discuss the company’s
innovative business model and review PAVmed’s lead products.
To access the live webcast of the presentation, please click
here. A replay will be available following the presentation.
About PAVmed
PAVmed Inc. (Nasdaq: PAVM) is a highly differentiated,
multi-product medical device company employing a unique business
model designed to advance products from concept to
commercialization much more rapidly and with significantly less
capital than the typical medical device company. This proprietary
model enables PAVmed to pursue an expanding multi-product pipeline
strategy with a view to enhancing and accelerating value creation.
PAVmed’s diversified pipeline of products address unmet clinical
needs, have attractive regulatory pathways and market opportunities
and encompass a broad spectrum of clinical areas including carpal
tunnel syndrome (CarpX™), medical infusions (NextFlo™ and
NextCath™), interventional radiology (PortIO™ and NextCath), tissue
ablation and cardiovascular intervention (Caldus™). The Company
intends to further expand its pipeline through engagements with
clinician innovators and leading academic medical centers. For
further information, please visit www.pavm.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160907006642/en/
For PAVmed Inc.InvestorsLHAKim Sutton Golodetz,
212-838-3777kgolodetz@lhai.comorMediaErich Sandoval,
917-497-2867esandoval@lazarpartners.com
Pavmed (MM) (NASDAQ:PAVMU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pavmed (MM) (NASDAQ:PAVMU)
Historical Stock Chart
From Jul 2023 to Jul 2024